Nevertheless, CLL-1 could not differentiate normal HSCs from cancerous stem cells since genetic mutations linked to MDS were also present in the CD34+/CD38−/CLL-1 − group [36]. Here, CLEC12A is linked to myelodysplastic syndrome.